
Ethnicity is independently correlated with the clinical benefit and irAEs to anti‐PD‐1 monotherapy, and the differences in clinical benefit by ethnicity are attributed to melanoma subtypes but not irAEs. Caucasian ethnicity is independently associated with better ORR/PFS in NAC/UP but shared similar ORR/PFS in acral/mucosal/uveal melanomas. Caucasians had higher rates of GI but lower rates of endocrine/liver/other‐rare‐types of irAEs regardless of melanoma subtype.
Like
Save
Share